Jae Hoon Jo

Title: Jae Hoon Jo: Innovator in Transnasal Pharmaceutical Composition

Introduction

Jae Hoon Jo is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of medications through novel formulations.

Latest Patents

Jae Hoon Jo holds a patent for a transnasal anticonvulsive pharmaceutical composition. This composition comprises diazepam as an active ingredient, along with water, a fatty acid ester, diethylene glycol monoethyl ether, ethanol, and sodium glycocholate. The formulation is designed to improve diazepam solubility and transmucosal permeability, allowing for effective treatment of convulsions through transnasal administration.

Career Highlights

Throughout his career, Jae Hoon Jo has worked with prominent companies in the pharmaceutical industry, including SK Holdings Co., Ltd. and SK Biopharmaceuticals Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Jae Hoon Jo has collaborated with several professionals in his field, including Kwon Ho Kim and Paramjeet Kaur. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical compositions.

Conclusion

Jae Hoon Jo's contributions to the field of pharmaceuticals, particularly through his patent for a transnasal anticonvulsive composition, highlight his role as an innovator. His work continues to influence the development of effective drug delivery systems.